BE794964A - NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEM - Google Patents

NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEM

Info

Publication number
BE794964A
BE794964A BE794964DA BE794964A BE 794964 A BE794964 A BE 794964A BE 794964D A BE794964D A BE 794964DA BE 794964 A BE794964 A BE 794964A
Authority
BE
Belgium
Prior art keywords
hypotensing
agents
preparing
new
new hypotensing
Prior art date
Application number
Other languages
French (fr)
Inventor
W N Beverung
R A Partyka
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE794964A publication Critical patent/BE794964A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical
BE794964D 1972-02-04 NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEM BE794964A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22372372A 1972-02-04 1972-02-04
US29145072A 1972-09-22 1972-09-22

Publications (1)

Publication Number Publication Date
BE794964A true BE794964A (en) 1973-08-02

Family

ID=26918072

Family Applications (1)

Application Number Title Priority Date Filing Date
BE794964D BE794964A (en) 1972-02-04 NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEM

Country Status (9)

Country Link
JP (1) JPS5623994B2 (en)
AU (1) AU475978B2 (en)
BE (1) BE794964A (en)
CA (1) CA1009652A (en)
DE (1) DE2305575A1 (en)
FR (1) FR2173988B1 (en)
GB (1) GB1418822A (en)
HK (1) HK15581A (en)
YU (2) YU210773A (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31617E (en) * 1972-02-04 1984-06-26 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
NL7807507A (en) 1977-07-25 1979-01-29 Hoffmann La Roche TRICYCLICAL CONNECTIONS.
US4146718A (en) * 1978-04-10 1979-03-27 Bristol-Myers Company Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
CA1131631A (en) * 1979-06-20 1982-09-14 Madhukar S. Chodnekar Quinazoline derivatives and pharmaceutical preparations
ZW16481A1 (en) * 1980-08-15 1982-03-10 Hoffmann La Roche Novel imidazoquinazoline derivatives
JPS6028979A (en) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd Imidazoquinazoline compound
WO1993003034A1 (en) * 1991-07-29 1993-02-18 Warner-Lambert Company Quinazoline derivatives as acetylcholinesterase inhibitors
AU705229B2 (en) 1994-08-09 1999-05-20 Eisai R&D Management Co., Ltd. Fused pyridazine compound
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0808947D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808968D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substitute quinazolines
ES2522968T3 (en) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (en) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (en) 2011-03-01 2018-10-19 辛纳吉制药公司 The method for preparing guanosine cyclic mono-phosphate agonist
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
MX2016001714A (en) 2013-08-09 2016-10-03 Ardelyx Inc Compounds and methods for inhibiting phosphate transport.
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN117062819A (en) * 2021-03-23 2023-11-14 北京生命科学研究所 Polycyclic compound and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760013A (en) * 1969-12-18 1971-06-08 Smith Kline French Lab IMIDAZO AND PYRIMIDO - (2,1-B) QUINAZOLINES, THEIR PREPARATION PROCESSES AND PHARMACEUTICAL COMPOSITIONS CONTAINING

Also Published As

Publication number Publication date
FR2173988A1 (en) 1973-10-12
CA1009652A (en) 1977-05-03
GB1418822A (en) 1975-12-24
AU5166873A (en) 1974-08-01
YU210773A (en) 1983-02-28
JPS4886894A (en) 1973-11-15
DE2305575A1 (en) 1973-08-09
FR2173988B1 (en) 1976-10-22
AU475978B2 (en) 1976-09-09
HK15581A (en) 1981-05-01
JPS5623994B2 (en) 1981-06-03
DE2305575C2 (en) 1989-01-12
YU151081A (en) 1983-12-31

Similar Documents

Publication Publication Date Title
BE794964A (en) NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEM
BE779203A (en) 2-HYDROCARBYLDITHIO-5-MERCAPTO-1, 3, 4, -THIADIAZOLES AND METHOD FOR PREPARING THEM,
BE799001A (en) NEW BENZODIAZEPINES AND METHODS FOR PREPARING THEM
BE799608A (en) SUBSTITUTED DIAMINES, AND METHODS FOR PREPARING THEM
BE758219A (en) ANTIBACTERIAL AGENTS AND METHOD FOR PREPARING THEM
BE790165A (en) NEW AMINOALCANOLS AND PROCESS FOR PREPARING THEM
BE804550A (en) BENZOFURAN DERIVATIVES AND PROCESS FOR PREPARING THEM
BE770531A (en) 3-FORMYL-CEPHALOSPORINS AND METHOD FOR PREPARING THEM
BE755884A (en) POLYALKENAMERES AND PROCESS FOR PREPARING THEM
BE808599A (en) NEW PYRAZOLODIAZEPINES AND METHOD FOR PREPARING THEM
BE793976A (en) NEW POLYAMINES AND PROCESS FOR PREPARING THEM
BE805047A (en) ANTI-ARRHYTHMIC AGENTS AND METHOD FOR PREPARING THEM
BE777246A (en) NEW ANTIBIOTICS AND METHOD FOR PREPARING THEM
BE811467A (en) TRIPEPTIDES AND PROCESS FOR PREPARING THEM
BE746576A (en) 4.20.22-BUFATRIENOLIDRHAMNOSIDE ETHERS AND METHOD FOR PREPARING THEM
BE804350A (en) ANTIBACTERIAL AGENTS AND METHOD FOR PREPARING THEM
BE799139A (en) ANTIBIOTIC DERIVATIVES AND PROCESS FOR PREPARING THEM
BE794532A (en) NEW 3-HYDROXYMETHYL-5-BENZYLIDENE-AZOLIDINONES AND PROCESS FOR MAKING THEM
BE800635A (en) ANTIBACTERIAL AGENTS AND METHOD FOR PREPARING THEM
BE804251A (en) ANTIBACTERIAL AGENTS AND METHOD FOR PREPARING THEM
BE816452A (en) NEW RADIOGRAPHIC CONTRAST AGENTS AND METHOD FOR PREPARING THEM
BE799098A (en) PYRAZOLE DERIVATIVES AND PROCESS FOR PREPARING THEM
BE806416A (en) NEW BINDERS AND PROCESS FOR PREPARING THEM
BE802336A (en) NEW HYDROXY-AMINOSTEROIDS AND PROCESS FOR THEIR PREPARATION
BE802727A (en) NEW POLYVINYL COMPOUNDS AND PROCESS FOR PREPARING THEM

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: BRISTOL MYERS CY

Effective date: 19930202